ESPERITE (ESP) updates on the current business.

February 17, 2020 Group News

  17 February 2020

Financial and business update

Esperite update the market

 

Esperite NV (Esperite, The Company) updates its shareholders on the current configuration and business of the company.

The company has taken distance from the operative part of its activities and focus its effort on turning itself in an investment company with a focus on Health Care and High-Tech Service.

***

read more

Cryo-Save acquires the commercial activities of Salveo Biotechnology in Switzerland, Spain, Italy, Portugal and Ukraine. Frédéric Amar, Non-executive Director, now deeply involved in the company strategy

December 24, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that it has signed an asset sale and purchase agreement to acquire all assets that are exclusively related to the distribution and commercial activities of the umbilical cord blood and umbilical cord tissue cryopreservation business of Salveo Biotechnology S.A., Switzerland and its subsidiaries, effective as of 1 January 2014.

read more